Annals of epidemiology · 2025
Cardiovascular disease burden attributable to estimated glomerular filtration rate: Insights from the ATTICA study (2002-2022).
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Damigou Evangelia, Florentin Matilda, Chrysohoou Christina, Anastasiou Costas, Barkas Fotios, Liberopoulos Evangelos, Sfikakis Petros P, Tsioufis Costas, Pitsavos Christos, Panagiotakos Demosthenes
Аннотация
PURPOSE: This study aimed to estimate cardiovascular disease (CVD) burden attributable to chronic kidney disease (CKD) and whether this burden varies in participants with different population characteristics.
METHODS: Our sample included 1988 adults free-of-CVD at baseline who took part in the ATTICA study (2002-2022). Estimated glomerular filtration rate (eGFR) was calculated based on the Chronic Kidney Disease Epidemiology Collaboration equation. CKD was defined in 2002, according to Kidney Disease Improving Global Outcomes (KDIGO) guidelines, as an eGFR ≤ 60 mL/min/1.73 m2. Combined fatal or non-fatal CVD events were assessed in 2006, 2012 and 2022 based on WHO-ICD-10. Population attributable fractions for multiadjusted models were computed based on Miettinen's formula. Stratified analyses were also performed.
RESULTS: At baseline, CKD prevalence was 4.7 % (n = 94). During the 20-year period, 36.1 % of participants developed CVD. A higher percentage of participants with CKD developed CVD compared to those without (77 % vs. 34 %). Approximately 6 out of a 100 new CVD cases (95 %CI: 1.7 %, 8.1 %) would have been prevented if CKD had been properly managed. Variations in these fractions were observed by sex and presence of comorbidities.
CONCLUSIONS: Albeit more research is warranted, our study supports that CKD should become a public health priority, and specifically a CVD priority.
METHODS: Our sample included 1988 adults free-of-CVD at baseline who took part in the ATTICA study (2002-2022). Estimated glomerular filtration rate (eGFR) was calculated based on the Chronic Kidney Disease Epidemiology Collaboration equation. CKD was defined in 2002, according to Kidney Disease Improving Global Outcomes (KDIGO) guidelines, as an eGFR ≤ 60 mL/min/1.73 m2. Combined fatal or non-fatal CVD events were assessed in 2006, 2012 and 2022 based on WHO-ICD-10. Population attributable fractions for multiadjusted models were computed based on Miettinen's formula. Stratified analyses were also performed.
RESULTS: At baseline, CKD prevalence was 4.7 % (n = 94). During the 20-year period, 36.1 % of participants developed CVD. A higher percentage of participants with CKD developed CVD compared to those without (77 % vs. 34 %). Approximately 6 out of a 100 new CVD cases (95 %CI: 1.7 %, 8.1 %) would have been prevented if CKD had been properly managed. Variations in these fractions were observed by sex and presence of comorbidities.
CONCLUSIONS: Albeit more research is warranted, our study supports that CKD should become a public health priority, and specifically a CVD priority.